查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434447

醫療保健人工智慧市場：按類型、應用和最終用戶分類 - 全球預測 2024-2030

Artificial Intelligence in Medicine Market by Type (Hardware, Services, Software), Application (Disease Diagnosis & Identification, Patient Care, Research & Drug Invention), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

醫療保健領域人工智慧市場規模預計2023年為44.4億美元，預計2024年將達到58.5億美元，2030年預計將達到309.7億美元，複合年成長率為31.97%。

醫療保健領域人工智慧的全球市場

主要市場統計
基準年[2023] 44.4億美元
預測年份 [2024] 58.5億美元
預測年份 [2030] 309.7億美元
複合年成長率（%） 31.97%
醫療保健市場中的人工智慧-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估醫療保健市場的人工智慧至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一個綜合工具，可以對醫療保健市場人工智慧供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-醫療保健人工智慧市場的市場規模和預測是多少？

2-在醫療保健市場的人工智慧預測期內，需要考慮投資哪些產品、細分市場、應用程式和領域？

3-醫療保健市場人工智慧的技術趨勢和法律規範是什麼？

4-醫療保健市場人工智慧主要供應商的市場佔有率是多少？

5-進入醫療保健人工智慧市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高藥物研發發現效率的需求不斷增加
      • 降低醫療費用的需求日益增加
      • 更加重視實施數位轉型實踐以實現成本節約
    • 抑制因素
      • 缺乏熟練的專業人員
    • 機會
      • 越來越關注人類感知人工智慧系統的開發
      • 精準醫療變得更加重要
    • 任務
      • 人們對資料隱私的擔憂日益加劇
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章醫療保健人工智慧市場：按類型

  • 硬體
  • 服務
  • 軟體

第7章 醫療保健領域的人工智慧市場：依應用分類

  • 疾病的診斷和鑑定
  • 患者照護
  • 研究和藥物研發

第8章醫療保健中的人工智慧市場：按最終用戶分類

  • 責任醫療組織與管理式醫療組織
  • 病人
  • 付款人
  • 製藥和生物技術公司
  • 提供者

第 9 章：美洲醫療保健領域的人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區醫療保健人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章：歐洲、中東和非洲醫療保健領域的人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Atomwise, Inc.
    • BenevolentAI
    • Berg LLC
    • Bioxcel Therapeutics, Inc.
    • Enlitic Inc.
    • Google LLC by Alphabet Inc.
    • InSilico Medicine
    • Intel Corporation
    • International Business Machines Corporation
    • Microsoft Corporation
    • NVIDIA Corporation
    • PathAI, Inc.
    • Recursion Pharmaceuticals, Inc.
    • Tempus Labs, Inc.
    • Verge Analytics, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-4330CC794AAE

[193 Pages Report] The Artificial Intelligence in Medicine Market size was estimated at USD 4.44 billion in 2023 and expected to reach USD 5.85 billion in 2024, at a CAGR 31.97% to reach USD 30.97 billion by 2030.

Global Artificial Intelligence in Medicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 4.44 billion
Estimated Year [2024] USD 5.85 billion
Forecast Year [2030] USD 30.97 billion
CAGR (%) 31.97%
Artificial Intelligence in Medicine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Medicine Market, highlighting leading vendors and their innovative profiles. These include Atomwise, Inc., BenevolentAI, Berg LLC, Bioxcel Therapeutics, Inc., Enlitic Inc., Google LLC by Alphabet Inc., InSilico Medicine, Intel Corporation, International Business Machines Corporation, Microsoft Corporation, NVIDIA Corporation, PathAI, Inc., Recursion Pharmaceuticals, Inc., Tempus Labs, Inc., and Verge Analytics, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hardware
    • Services
    • Software
  • Application
    • Disease Diagnosis & Identification
    • Patient Care
    • Research & Drug Invention
  • End User
    • Accountable Care Organizations & Managed Care Organizations
    • Patients
    • Payers
    • Pharmaceutical & Biotechnology Companies
    • Providers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Intelligence in Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Medicine Market?

3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Medicine Market?

4. What is the market share of the leading vendors in the Artificial Intelligence in Medicine Market?

5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Intelligence in Medicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand to improve the efficiency of drug discovery
      • 5.1.1.2. Increase in need to reduce healthcare costs
      • 5.1.1.3. Increased emphasis on adoption of digital transformation practices to realize cost savings
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising focus on developing human-aware artificial intelligence systems
      • 5.1.3.2. Growing importance of precision medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Growing concerns regarding data privacy
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Intelligence in Medicine Market, by Type

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Artificial Intelligence in Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Disease Diagnosis & Identification
  • 7.3. Patient Care
  • 7.4. Research & Drug Invention

8. Artificial Intelligence in Medicine Market, by End User

  • 8.1. Introduction
  • 8.2. Accountable Care Organizations & Managed Care Organizations
  • 8.3. Patients
  • 8.4. Payers
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Providers

9. Americas Artificial Intelligence in Medicine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Intelligence in Medicine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Intelligence in Medicine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Atomwise, Inc.
    • 13.1.2. BenevolentAI
    • 13.1.3. Berg LLC
    • 13.1.4. Bioxcel Therapeutics, Inc.
    • 13.1.5. Enlitic Inc.
    • 13.1.6. Google LLC by Alphabet Inc.
    • 13.1.7. InSilico Medicine
    • 13.1.8. Intel Corporation
    • 13.1.9. International Business Machines Corporation
    • 13.1.10. Microsoft Corporation
    • 13.1.11. NVIDIA Corporation
    • 13.1.12. PathAI, Inc.
    • 13.1.13. Recursion Pharmaceuticals, Inc.
    • 13.1.14. Tempus Labs, Inc.
    • 13.1.15. Verge Analytics, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS & IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH & DRUG INVENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ACCOUNTABLE CARE ORGANIZATIONS & MANAGED CARE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 147. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET LICENSE & PRICING